Trading Profile: Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties worldwide. It offers implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities; and implantable pacemaker systems used to manage slow or irregular heart rhythms. The company also provides coronary stents, which are used in the treatment of coronary artery disease; and products used to treat patients with atherosclerosis. Its product offerings include balloon catheters, rotational atherectomy systems, guide wires, guide catheters, embolic protection devices, and diagnostic catheters used in percutaneous transluminal coronary angioplasty, as well as Apex pre-dilatation balloon catheter. In addition, the company markets a family of intraluminal catheter-directed ultrasound imaging catheters and systems for use in coronary arteries and heart chambers, as well as certain peripheral vessels. Further, it is developing a device for percutaneous aortic valve replacement to treat patients with severe aortic stenosis; and less-invasive medical technologies used treatment of rate and rhythm disorders of the heart. Additionally, the company sells products designed to treat patients with peripheral disease; and products designed to treat patients with non-vascular disease. It also offers a system that is designed to capture embolic material that may become dislodged during a procedure; products to diagnose, treat, and ease various digestive diseases; devices to diagnose, treat, and ease pulmonary disease systems within the airway and lungs; devices to treat various urological and gynecological disorders; products designed to treat patients with urinary stone disease, stress urinary incontinence, pelvic organ prolapse and excessive uterine bleeding; stone management products; and system for the management of chronic pain. The company was founded in 1979 and is headquartered in Natick, Massachusetts.
»»» Detailed Company Profile & Chart
Boston Scientific Corp current day financials: 2024-04-19 10:32:45pm| Symbol | Name | Purchase price | Last Price | Change | % Change |
|---|---|---|---|---|---|
| 0.00 | |||||
Recent BSX News from Yahoo Finance & Seeking Alpha
Unveiling Boston Scientific (BSX) Q1 Outlook: Wall Street Estimates for Key Metrics »
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2024.
FDA Classifies Boston Scientific's Recall For Device To Stop Blood Flow As 'Most Serious' »
On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An investigation determined that delivery of Obsidio Embolic using the aliquot technique, a commonly used delivery method in embolization procedures, for lower gastrointestinal (GI) bleeding embolization, implies a high risk of bowel ischemia. The most serious and the most common adverse health consequenc
Boston Scientific recalls blood-blocking agent linked to 2 deaths »
Seven injuries and 11 incidents were also associated with the safety issue.
Boston Sci issues corrective recall for Obsidio Embolic over safety concerns »
UPDATE 1-FDA classifies recall of Boston Scientific device as 'most serious' »
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's device used to block blood flow during excessive bleeding or hemorrhaging as "most serious". An investigation showed that Boston's device, Obsidio Embolic, when used with a specific technique posed a higher risk of bowel ischemia during procedures to stop gastrointestinal (GI) bleeding, the agency said. Bowel ischemia describes disorders that occur when blood flow to your intestines decrease, causing severe abdominal pain.
Older Archived News Boston Scientific Corp
- Insider Trading Alert - BSX, PGC And BANR Traded By Insiders.
- 3 Things to Know Before Selling Boston Scientific Group (BSX).
- Boston Scientific CEO to Add Chairman Title as Nicholas Retires.
- Medtronic Delivering Shareholder Value Ahead.
- Insider Trading Alert - BSX, PRO And UVV Traded By Insiders.
- Here’s Why Boston Scientific (BSX) Stock is Rising Today.
- Trade-Ideas: Boston Scientific (BSX) Is Today's Post-Market Leader Stock.
- Boston Scientific (BSX) Earnings Report: Q4 2015 Conference Call Transcript.
- Boston Scientific (BSX) Stock Declining After Earnings Results.
- Trade-Ideas: Boston Scientific (BSX) Is Today's Unusual Social Activity Stock.Load More News...
